MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 138 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,618,971 | -8.3% | 45,323 | +45.0% | 0.04% | -4.9% |
Q2 2023 | $7,220,136 | +5.9% | 31,256 | +11.1% | 0.04% | -10.9% |
Q1 2023 | $6,815,985 | -77.7% | 28,135 | -73.3% | 0.05% | -82.0% |
Q4 2022 | $30,589,448 | +614.0% | 105,390 | +59.9% | 0.26% | +456.5% |
Q3 2022 | $4,284,000 | +92.1% | 65,921 | +111.6% | 0.05% | +119.0% |
Q2 2022 | $2,230,000 | -50.9% | 31,160 | -32.7% | 0.02% | -22.2% |
Q1 2022 | $4,542,000 | +46.7% | 46,287 | +26.7% | 0.03% | +68.8% |
Q4 2021 | $3,097,000 | +23.4% | 36,547 | +16.2% | 0.02% | -5.9% |
Q3 2021 | $2,510,000 | +6.6% | 31,456 | +30.2% | 0.02% | +13.3% |
Q2 2021 | $2,354,000 | -28.8% | 24,165 | -14.5% | 0.02% | -34.8% |
Q1 2021 | $3,307,000 | +326.7% | 28,275 | +305.4% | 0.02% | +187.5% |
Q4 2020 | $775,000 | -37.9% | 6,974 | -33.6% | 0.01% | -46.7% |
Q3 2020 | $1,247,000 | +44.8% | 10,506 | +38.2% | 0.02% | +25.0% |
Q2 2020 | $861,000 | -39.7% | 7,603 | -51.5% | 0.01% | -45.5% |
Q4 2019 | $1,429,000 | -51.6% | 15,679 | -54.2% | 0.02% | -52.2% |
Q3 2019 | $2,951,000 | -28.2% | 34,230 | -12.7% | 0.05% | -36.1% |
Q2 2019 | $4,111,000 | +4.2% | 39,219 | +24.5% | 0.07% | +12.5% |
Q1 2019 | $3,947,000 | – | 31,511 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |